HARROW, INC. (HROW)

↓ Download CSV

CIK 0001360214 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, HARROW, INC. reported revenue of $272.30M, up 36.4% from the prior year. The company ran a net loss, with a net margin of -1.9% and a gross margin of 75.1%. It held $399.48M in total assets against $347.39M in total liabilities.

Key ratios (FY2025)

75.1%
Gross margin
11.2%
Operating margin
-1.9%
Net margin
-9.8%
Return on equity
+36.4%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$272.30M$199.61M$130.19M$88.59M$72.48M$48.87M$51.16M$41.37M$26.77M
Cost of Revenue$67.93M$49.24M$39.64M$25.38M$18.21M$14.46M$16.75M$16.52M$13.51M
Gross Profit$204.37M$150.37M$90.55M$63.21M$54.26M$34.41M$34.42M$24.85M$13.27M$10.11M
Operating Income$30.52M$8.82M$431.0K$1.92M$1.61M$385.0K-$4.79M-$5.22M-$12.16M-$15.88M
Net Income-$5.14M-$17.48M-$24.41M-$14.09M-$18.01M-$3.36M$168.0K$14.62M-$11.98M-$19.09M
EPS (Diluted)$-0.14$-0.49$-0.75$-0.51$-0.69$-0.13$0.01$0.67$-0.60
Total Assets$399.48M$388.97M$312.16M$157.38M$98.33M$57.47M$59.09M$49.45M$23.92M$27.25M
Total Liabilities$347.39M$319.67M$241.75M$130.14M$87.40M$30.65M$31.67M$24.70M$21.30M$20.82M
Shareholders' Equity$52.45M$69.65M$70.77M$27.59M$11.29M$27.18M$27.71M$24.75M$2.62M$6.43M
Cash & Equivalents$72.93M$47.25M$74.08M$96.27M$42.17M$4.10M$4.75M$4.02M$8.85M
Operating Cash Flow$43.86M-$22.20M$3.84M$1.71M$5.08M-$1.10M$950.0K$687.0K-$8.80M-$11.21M
Capital Expenditures$887.0K$1.59M$1.46M$2.60M$1.79M$862.0K$1.47M$1.77M$772.0K$6.89M
Shares Outstanding37.23M35.62M35.17M29.90M26.90M25.75M25.53M24.34M20.62M18.63M